RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

NCT02871843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Oligodendroglioma
Anaplastic Oligodendroglioma

Interventions

DRUG: RRx-001 dose escalation with TMZ + RT
RADIATION: Radiation
DRUG: Fixed dose Temozolomide (75 mg/m2)
DRUG: TMZ Maintenance

Sponsor

EpicentRx, Inc.